HealthStream, Inc.
HSTM Healthcare Health Information Services
HealthStream, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $304.1 million, up 4.26% from fiscal 2024. In the quarter to June 2026, revenue grew 12.6%, EPS grew 27.8% and free cash flow grew 362.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five.
Follow HSTM
HealthStream, Inc. (HSTM) Beneish M-score
HealthStream, Inc.'s Beneish M-score for fiscal 2025 is −2.75; values above −1.78 are the model's flag for possible earnings manipulation — a statistical screen, not a finding.
Beneish M-score, annual
Embed this chart
Annual newest first
| Period | Beneish M-score | Change (points) |
|---|---|---|
| FY2025 | −2.75 | 0.16 |
| FY2024 | −2.90 | 0.14 |
| FY2023 | −3.04 | (0.33) |
| FY2022 | −2.71 | 0.29 |
| FY2021 | −3.01 | (0.93) |
| FY2020 | −2.08 | 0.99 |
| FY2019 | −3.07 | (0.32) |
| FY2018 | −2.75 | 0.34 |
| FY2017 | −3.09 | (0.66) |
| FY2016 | −2.43 | 0.03 |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Days’ sales in receivables index | 1.06 | — | 0.97 | |
| Gross margin index | 1.03 | — | 0.54 | |
| Asset quality index | 1.10 | — | 0.45 | |
| Sales growth index | 1.04 | — | 0.93 | |
| Depreciation index | 0.99 | — | 0.11 | |
| SG&A index | 0.96 | — | −0.16 | |
| Total accruals to total assets | (0.09) | — | −0.40 | |
| Leverage index | 1.05 | — | −0.34 | |
| Beneish M-score | Low — no pattern the model associates with manipulation | −2.75 | ||
How the Beneish M-score works
M = −4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI (Beneish, 1999): eight changes in the accounts from one fiscal year to the next, which the model weighs for the pattern seen in companies that later restated their earnings. Higher is worse.
| below −2.22 | Low — no pattern the model associates with manipulation |
|---|---|
| −2.22 to −1.78 | Elevated |
| above −1.78 | Flagged by the model |
−1.78 is the cut-off usually quoted from the paper, −2.22 a common conservative one. A statistical screen, not a finding of wrongdoing.
When asset quality, depreciation or SG&A cannot be worked out, that index is set to 1, as Beneish did, and the breakdown says so; with all three missing there is no score. Depreciation includes amortisation, and asset quality leaves out securities. Not worked out for banks, insurers and REITs.
Beneish M-score against peers
| Company | Beneish M-score |
|---|---|
| MDRX Veradigm Inc. compare | −3.6× |
| SOPH SOPHiA GENETICS SA compare | −3.3× |
| TDOC Teladoc Health, Inc. compare | −3.3× |
| OMCL Omnicell, Inc. compare | −2.9× |
| CERT Certara, Inc. compare | −2.8× |
| HSTM HealthStream, Inc. | −2.7× |
| OMDA Omada Health, Inc. compare | −2.6× |
| GDRX GoodRx Holdings, Inc. compare | −2.4× |
| PHR Phreesia, Inc. compare | −2.1× |
What Beneish M-score is
The Beneish M-Score combines eight year-on-year changes in the accounts into a statistical screen for patterns seen in companies that overstated earnings.
−4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI